Amundi Asset Management US’s Globus Medical GMED Stock Holding History

Amundi Asset Management US’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-136	Closed	-$7K	–	1519
2020 Q3	$7K	Hold	136	–	–	﹤0.01%	1549
2020 Q2	$6K	Buy	136 +51	+60%	+$2.46K	﹤0.01%	1573
2020 Q1	$4K	Sell	85 -39,618	-100%	-$1.96M	﹤0.01%	1563
2019 Q4	$2.34M	Buy	39,703 +34,277	+632%	+$1.86M	﹤0.01%	1089
2019 Q3	$277K	Hold	5,426	–	–	﹤0.01%	1401
2019 Q2	$230K	Hold	5,426	–	–	﹤0.01%	1455
2019 Q1	$268K	Hold	5,426	–	–	﹤0.01%	1389
2018 Q4	$235	Buy	5,426 +2,044	+60%	+$102K	﹤0.01%	1365
2018 Q3	$192K	Hold	3,382	–	–	﹤0.01%	1456
2018 Q2	$171K	Buy	3,382 +107	+3%	+$5.58K	﹤0.01%	1435
2018 Q1	$163K	Buy	+3,275	New	+$154K	﹤0.01%	1369

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Amundi Asset Management US's GMED Position: Q4 2020 in Review

Amundi Asset Management US sold out of Globus Medical (GMED) in Q4 2020, closing a stake of 136 shares — an estimated $7K sold.

Amundi Asset Management US first reported a position in GMED in Q1 2018 and held it in 11 quarters. The position peaked at $2.34M in Q4 2019. 348 funds tracked by Wall St. Rank hold GMED as of Q4 2020.

Amundi Asset Management US reported no remaining Globus Medical position as of Q4 2020 after selling out during the quarter.
Amundi Asset Management US sold 136 Globus Medical shares in Q4 2020, an estimated $7K.
Amundi Asset Management US first reported a position in Globus Medical in Q1 2018 and held it in 11 quarters.
Amundi Asset Management US's Globus Medical position peaked at $2.34M in Q4 2019.
348 funds tracked by Wall St. Rank held Globus Medical as of Q4 2020.

Based on Amundi Asset Management US's 13F filing for Q4 2020, filed 16 Feb 2021.